Review on Rosuvastatin and Fenofibrate
Devendra Singh, Kiruthiga Shankar Kumar, Nupur Mahadeokar
Abstract
Open-access reader
Devendra Singh, Kiruthiga Shankar Kumar, Nupur Mahadeokar
Abstract
Open-access reader
This article is an examination of a review on Rosuvastatin and Fenofibrate. The scientific development and subsequent study of the effects that Rosuvastatin and Fenofibrate have, which taken individually and in combination, on various diseases, continues to influence the researchers all over the globe today. This article examines the research done and published by researchers and scientists. Consideration of current trends and data in scientific queries and demonstrates further aspects of Rosuvastatin and Fenofibrate. Additionally, this article explores the effect that rosuvastatin has on thromboinflammation, platelet volume and dyslipidaemia, the effects of Fenofibrate on diabetic retinopathy, non-alcoholic fatty liver disease and dyslipidaemia and finally the combined effects of rosuvastatin and fenofibrate on prostate cancer, Ischemic stroke and hypolipidemia.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This article is an examination of a review on Rosuvastatin and Fenofibrate. The scientific development and subsequent study of the effects that Rosuvastatin and Fenofibrate have, which taken individually and in combination, on various diseases, continues to influence the researchers all over the globe today. This article examines the research done and published by researchers and scientists. Consideration of current trends and data in scientific queries and demonstrates further aspects of Rosuvastatin and Fenofibrate. Additionally, this article explores the effect that rosuvastatin has on thromboinflammation, platelet volume and dyslipidaemia, the effects of Fenofibrate on diabetic retinopathy, non-alcoholic fatty liver disease and dyslipidaemia and finally the combined effects of rosuvastatin and fenofibrate on prostate cancer, Ischemic stroke and hypolipidemia.
Key concepts: Fenofibrate, Rosuvastatin, Medicine, Internal medicine, Intensive care medicine